Meet Researchers, Doctors, Patients
According to David Weber, CEO of Otonomy, there are signs of heightened interest among investors in hearing science. This is good news for all of us. We take a deep dive with Otonomy’s executives into their drug pipeline, covering hearing loss and tinnitus.
While curing tinnitus remains a conundrum, important advances are being made in the field of hearing regeneration, which might also benefit tinnitus sufferers. The Hough Ear Institute talks about two hearing restoration treatments under development.
Learn all you’ve wanted to know about the newest tinnitus treatment on the market! Many of you have been waiting to hear more about Lenire, the tinnitus treatment device launched by Neuromod Devices. Well, this is your chance, tune in and listen to our interview with Neuromod’s CEO.
Do you want to know what clinical evidence says about different treatments for tinnitus? This episode explores the new European Clinical Practice Guidelines for tinnitus, and how they can help patients and doctors; and hopefully inspire more thorough testing of new and existing treatments for tinnitus.